Searched for
SAGENT
Who is Anjali Sud, the Indian-American elected on Harvard's overseas board amid Trump's tiff? Know her education, career & net worthAnjali Sud, an Indian-American business executive, joins Harvard's Board of Overseers. She fills the vacancy after Mark Carney's resignatio...- Kedaara, TA Associates vie for minority stake in Sagent PharmaKedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Invest...
- Buy Dr. Reddy's Laboratories, target Rs 3,350: Edelweiss Financial ServicesBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3350.0 .
- DCS spots a star in Indian SaaS, consumer internet spaceDCS advisory is a recently formed North America-based advisory entity which combines the operations of two US-based firms Signal Hill and S...
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Torrent, Dr Reddy’s, Aurobindo, Cipla, Lupin in race to buy SagentValuation is expected to be upwards of $500 million (Rs 3,400 crore), for which large generic drug makers and financial investors like glob...
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...
- Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing listThe club of the fastest growing generic companies in the world is dominated by US companies , led by US-based Sagent Pharma, which witnesse...
- Strides Arcolab gets USFDA nod for injectable AcetazolamideDrug firm Strides Arcolab today said it has received US health regulator's approval to sell injectable Acetazolamide in the American market.
- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- Strides Arcolab gets USFDA approval for generic injectable anaestheticStrides said it has received two approvals from the US health regulator for supply of generic injectable Bupivacaine Hydrochloride USP.
- Strides gets USFDA approval for anti-bacterial injectionThe product will be available in three single-dose vial sizes and in pharmacy bulk packaging, Strides Arcolab said in a statement.
- Strides Arcolab, US FDA, Polymyxin B, Onco TherapiesBangalore-based Strides Arcolab received European and US FDA approval on Friday for two of its products.
- Strides Arcolab gets approval for facility, anti-bacterial injectionDrug firm Strides Arcolab today said it has received approval from the European authorities for its Bangalore-based oncology facility.
- Strides Arcolab gets USFDA nod for Adenosine injectionDrug firm Strides Arcolab today said it has received approval from the US health regulator for additional package size of Adenosine injecti...
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Pfizer recalls drug from USPFIZER has recalled a drug made by an Indian partner from the US market while another local partner of the world’s largest drugmaker receiv...
- KEC Intl to acquire US' SAE Towers for Rs 440 crKEC International announced that it will buy US-based SAE Towers Holdings for an enterprise value — market capitalisation plus debt — of ar...
- Strides gets US approval for migraine drugDrug maker Strides Arcolab on Monday said US health regulator Food and Drug Administration has given its nod for sale of Sumatriptan Succin...
- Claris recalls three anti-biotic drugs from USAhmedabad-based drug-maker Claris Lifesciences on Monday recalled three antibiotic drugs from the US market following an alert issued by th...
Load More
